Flunitrazolam Pellets – 0.25mg

A. Introduction

Flunitrazolam Pellets 0.25mg represent premium laboratory-grade research chemical designed for scientific institutions studying triazolobenzodiazepine derivatives. As 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-triazolo[4,3-a]benzodiazepine, these precisely dosed 0.25mg pellets provide researchers consistent reference material for molecular interaction studies, analytical method development, and chemical characterization in controlled laboratory environments.

B. Scientific Overview

Flunitrazolam belongs to the triazolobenzodiazepine class of compounds and functions as a potent ligand for GABA-A receptor research. It serves primarily as an analytical reference standard for chromatographic and spectroscopic investigations of benzodiazepine analogs.
In laboratory contexts, triazolobenzodiazepines like Flunitrazolam are examined for structural properties, binding affinities in receptor assays, and performance in validated analytical workflows under strictly controlled conditions.

C. Product Specifications

• Form: Precisely pressed 0.25mg laboratory pellets for accurate handling

• Chemical Name: 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-triazolo[4,3-a]benzodiazepine

• CAS Number: Not assigned (research chemical)

• Molecular Formula: C17H12BrFN6OCX17HX12BrFNX6O

• Molecular Weight: 371.20 g/mol

• Purity: ≥98% (third-party verified, typical batch)

• Storage Conditions: Store in freezer (-20°C) protected from light and moisture for optimal stability

D. Laboratory Use Context

Flunitrazolam Pellets 0.25mg are positioned exclusively for in-vitro analytical research, serving as reference standards for method validation, receptor binding assays, detection in complex matrices, and physicochemical characterization using HPLC, LC-MS, NMR spectroscopy, and other advanced techniques.
Researchers employ these pellets in controlled laboratory protocols for forensic toxicology, pharmaceutical analysis, and GABA-A receptor ligand investigations. All applications must adhere to institutional safety protocols and regulations.

E. Quality & Testing

Every batch of Flunitrazolam Pellets 0.25mg undergoes comprehensive quality control:

• Third-party Certificate of Analysis (COA) available upon request

• Full batch traceability with complete documentation

• Independent verification of identity, purity, and uniformity

• Manufactured under ISO-compliant conditions for research-grade reliability

F. Shipping & Handling

Discreet worldwide shipping provided to verified research institutions and laboratories. Pellets securely packaged in child-resistant containers with proper chemical research labeling for safe transit and regulatory compliance. Full tracking provided; researchers must confirm import legality prior to ordering.

G. Compliance Disclaimer

For Research Use Only. Not for human consumption.
This product supplied strictly for laboratory and analytical research by qualified professionals. Not intended for human or veterinary use, ingestion, inhalation, or consumption. No statements regarding biological activity beyond controlled in-vitro research applications.
Buyers must be authorized researchers or institutions accepting full responsibility for compliance with applicable regulations. Seller disclaims liability for unauthorized use.